<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>serum ultra long-chain fatty acid panel is_biomarker_for colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>serum ultra long-chain fatty acid panel</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>colorectal cancer</strong>
</div>
<div class="entity-id">UNKNOWN:serum ultra long-chain fatty acid panel &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:0%;--color:#d62728"></div>
<div class="stat-row">
  <span>Class: Text Derived (0.01)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 73.13<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.01 (Text Derived, 1 paper)<br>Score from 74 citations: <strong>73.13</strong><br><span style="color:#888">43&times; extends (+61.13) &middot; 31&times; supports (+12.00)</span><br>Neighbourhood: 79.20</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#d62728" title="Text Derived"></span><span>Text Derived</span><a href="https://doi.org/10.1186/1741-7015-8-13">10.1186/1741-7015-8-13</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 74 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:72px"></span><span>31</span><span class="cite-subtotal">&middot; +12.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolomics profiling — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/2bc1aba3ce45d442.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolite panel — predicts → Colorectal Cancer</span><span class="cite-claim-weight">+1.00</span><a href="../claim/760a9d763e59f3da.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabonomics — predicts → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/590e5ebf9fbb8ef6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolic profiling (PLS-DA) — distinguishes → Colorectal Cancer vs Healthy Controls</span><span class="cite-claim-weight">+0.50</span><a href="../claim/75a24f6e37713eb4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fatty acid biosynthesis pathway metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/21873dd2e933f075.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxidative pathway metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bf56c4b7d88b1574.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">glycolytic pathway metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/092d4af1543c3af5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">polyamine pathway metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7fdc5cbaa76cd492.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolomic profile — distinguishes → colorectal cancer tumor vs non-neoplastic epithelium</span><span class="cite-claim-weight">+0.79</span><a href="../claim/a554a9806de1afff.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Polyunsaturated fatty acid-containing Phosphatidylcholines (PCs) — decreases → Colorectal Carcinoma</span><span class="cite-claim-weight">+0.79</span><a href="../claim/d024d59e503a0b44.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GOT-MS — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/89bc9c569077e1c3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GOT-MS (595 precursor ions / 1890 MRM transitions) — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7dd1caecf8f7dd19.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">succinate — increases → colorectal cancer</span><span class="cite-claim-weight">+1.00</span><a href="../claim/ce532437c6d43088.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Plasma metabolite panel (29 metabolites) — distinguishes → Colorectal Cancer (Stage 0/I/II)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/95c047c5809cf90e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Multiple logistic regression metabolite model — predicts → Colorectal Cancer (Stage 0/I/II)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/efcf3b9a8d3c16a3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Multiple logistic regression metabolite model — distinguishes → Colorectal Cancer Stage 0</span><span class="cite-claim-weight">+0.50</span><a href="../claim/ebb74bfb7b04f8d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Metabolomics panel — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/11a05f5844d42b62.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Metabolomics panel — predicts → Colorectal Cancer recurrence</span><span class="cite-claim-weight">+0.50</span><a href="../claim/cbeb78b603c334c6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolome — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">+0.79</span><a href="../claim/de0929f616e4392e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Kynurenine — increases → Colorectal cancer</span><span class="cite-claim-weight">+0.02</span><a href="../claim/aed7e7722b9db93d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Tryptophan — decreases → Colorectal cancer</span><span class="cite-claim-weight">+0.02</span><a href="../claim/8ae0066f06108bcc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Carnitine — decreases → Colorectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/9177067a4016c707.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Phosphatidylcholine — decreases → Colorectal cancer</span><span class="cite-claim-weight">+0.02</span><a href="../claim/a224e4082d626ce5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Indoleacetic acid — decreases → Colorectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/ed8db148b5f825a6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Serum metabolome panel — predicts → Pathological complete response to neoadjuvant chemoradiation in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/8f1cb6c1972c454c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Glycerophosphocholine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/d3bb9891d357bc29.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Taurine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/b8f182218b41caec.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Lysophosphatidylcholine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/61ac2deeff608e5d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Pre-treatment serum metabolome — predicts → Tumor regression grade in locally advanced rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/5c859bcad8ee82fe.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Glycerophosphocholine — increases → Pathological complete response to chemoradiation in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/e1efebf2b733d62b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/25bc564792710f83.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>43</span><span class="cite-subtotal">&middot; +61.13</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">proline — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/68a4d4b4109158b1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">taurine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+5.57</span><a href="../claim/c46d79d6a72d684c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">lactate — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+7.61</span><a href="../claim/adfed5c541f5d3e1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">choline — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/80b56d22c3e762c6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">inositol — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/0007c04a54724eeb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">glycine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/3ad853dd9decc127.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphocholine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/3c7f0e5490e49cd7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phenylalanine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+1.20</span><a href="../claim/2b2ddbab069d3634.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">alanine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+6.20</span><a href="../claim/4799c6376c53277f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">threonine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/cd295df1787f41b3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">valine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/87b4423b3c62d7b3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">leucine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/54a0fb9475340f0a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">glucose — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/7a61f5127ff4ee48.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Succinic acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+6.20</span><a href="../claim/3d51c671c90c377a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">choline — is_biomarker_for → breast cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/591d1d801d540b32.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphocholine — is_biomarker_for → breast cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/4bb0559a84176206.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sarcosine — is_biomarker_for → prostate cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ec872cab466e5697.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sarcosine — distinguishes → metastatic prostate cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/514fffa1e16002e7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolomics profiling — distinguishes → liver cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/4e4cf9d585511bb8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">aerobic glycolysis — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/3d407987f1de85a6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">purine metabolism — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/7ff727659ec937de.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolomics — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/dc95d11d8e31e708.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">taurine — decreases → colorectal cancer liver metastasis</span><span class="cite-claim-weight">+1.20</span><a href="../claim/085d425052ce8882.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">glucose — is_biomarker_for → colorectal cancer liver metastasis</span><span class="cite-claim-weight">+6.20</span><a href="../claim/b31e97b86916a1ac.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">candidate biomarker metabolites — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/c92a373ef1ba1de6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Fumarate — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/fe18d4c5745f58f2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipid metabolites — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8dc61ea80945ac04.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Nucleotide metabolites — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ae901ffe8308f6a5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Kynurenine/Tryptophan ratio — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/d7102117614897e4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Kynurenine/Tryptophan ratio — distinguishes → Colorectal cancer stages I-IV vs healthy controls</span><span class="cite-claim-weight">+0.01</span><a href="../claim/a1bfe1ffb9da5439.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Sphingomyelin — decreases → Colorectal cancer</span><span class="cite-claim-weight">+0.02</span><a href="../claim/49de0da24823e6e9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Kynurenine — is_biomarker_for → Colorectal cancer stage</span><span class="cite-claim-weight">+1.55</span><a href="../claim/15709a5e8bd22547.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Quinolinic acid — increases → Colorectal cancer</span><span class="cite-claim-weight">+0.02</span><a href="../claim/fc35fbeafad8cc53.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Hypoxanthine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/29911b76436518a8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Xanthine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/3f23f075b8470c9b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Inosine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/06310cfe572ab0ec.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Phenylalanine — distinguishes → Pathological complete response vs non-complete response in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/f44c784f3ebfd339.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Serum purine metabolites (hypoxanthine, xanthine, inosine) — is_biomarker_for → Locally advanced rectal cancer pathological complete response</span><span class="cite-claim-weight">+0.01</span><a href="../claim/3277beb972cb2688.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Taurine — correlates_with → Pathological complete response to chemoradiation in rectal cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/3d0a94a0b2d89900.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">tryptophan — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+1.39</span><a href="../claim/a42864072a5c69c5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">bile acids — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/4013d9365dfef12a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Metabolomic profile — distinguishes → Prostate cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/16223831acef3951.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Metabolomic profile — distinguishes → Liver cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/9418c83748c2452a.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>4d243d490253bd21</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:serum ultra long-chain fatty acid panel">UNKNOWN:serum ultra long-chain fatty acid panel</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
